These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 1654207

  • 1. Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.
    Redondo M, Concha A, Oldiviela R, Cueto A, Gonzalez A, Garrido F, Ruiz-Cabello F.
    Cancer Res; 1991 Sep 15; 51(18):4948-54. PubMed ID: 1654207
    [Abstract] [Full Text] [Related]

  • 2. Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation.
    Redondo M, Ruiz-Cabello F, Concha A, Cabrera T, Pérez-Ayala M, Oliva MR, Garrido F.
    Cancer Res; 1991 May 01; 51(9):2463-8. PubMed ID: 1849792
    [Abstract] [Full Text] [Related]

  • 3. Class I major histocompatibility complex antigens and tumor ploidy in breast and bronchogenic carcinomas.
    Redondo M, Concha A, Ruiz-Cabello F, Morell M, Esteban F, Talavera P, Garrido F.
    Cancer Detect Prev; 1997 May 01; 21(1):22-8. PubMed ID: 9043759
    [Abstract] [Full Text] [Related]

  • 4. Complementary reactivities of anti-carcinoembryonic antigen and antitumor-associated glycoprotein 72 monoclonal antibodies in lung carcinomas.
    Battista P, Muraro R, Mammarella S, Curia MC, Colasante A, Rosini S, Lesti G, Sacco R, French D, Frati L.
    Cancer Res; 1990 Nov 01; 50(21):6987-94. PubMed ID: 1698547
    [Abstract] [Full Text] [Related]

  • 5. Lack of correlation between codon 12 K-ras mutations and major histocompatibility complex antigens in bronchogenic carcinomas.
    Redondo M, Rodriguez F, Hortas ML, Concha A, Morell M, Garrido F, Ruiz-Cabello F.
    Cancer Detect Prev; 1997 Nov 01; 21(5):412-7. PubMed ID: 9307844
    [Abstract] [Full Text] [Related]

  • 6. Phenotypic heterogeneity studied by immunohistochemistry and aneuploidy in non-small cell lung cancers.
    Pujol JL, Simony J, Laurent JC, Richer G, Mary H, Bousquet J, Godard P, Michel FB.
    Cancer Res; 1989 May 15; 49(10):2797-802. PubMed ID: 2540908
    [Abstract] [Full Text] [Related]

  • 7. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
    Hilders CG, Munoz IM, Nooyen Y, Fleuren GJ.
    Gynecol Oncol; 1995 Jun 15; 57(3):366-75. PubMed ID: 7774840
    [Abstract] [Full Text] [Related]

  • 8. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
    Möller P, Momburg F, Koretz K, Moldenhauer G, Herfarth C, Otto HF, Hämmerling GJ, Schlag P.
    Cancer Res; 1991 Jan 15; 51(2):729-36. PubMed ID: 1985791
    [Abstract] [Full Text] [Related]

  • 9. Loss of heterozygosity at 6p21 underlying [corrected] HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.
    Yang Y, Zhang J, Miao F, Wei J, Shen C, Shen Y, Xie W.
    Tissue Antigens; 2008 Aug 15; 72(2):105-14. PubMed ID: 18721270
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. HLA class II expression in well differentiated thyroid carcinoma: correlation with clinicopathological features.
    Knoll MR, Schwab M, Oestreich K, Rumstadt B, Hagmüller E.
    J Exp Clin Cancer Res; 1997 Jun 15; 16(2):177-82. PubMed ID: 9261744
    [Abstract] [Full Text] [Related]

  • 12. Loss of HLA haplotype in lung cancer cell lines: implications for immunosurveillance of altered HLA class I/II phenotypes in lung cancer.
    Hiraki A, Kaneshige T, Kiura K, Ueoka H, Yamane H, Tanaka M, Harada M.
    Clin Cancer Res; 1999 Apr 15; 5(4):933-6. PubMed ID: 10213231
    [Abstract] [Full Text] [Related]

  • 13. Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment.
    Nissen MH, Plesner T, Larsen JK, Olesen BK, Ernst P.
    Clin Exp Immunol; 1985 Feb 15; 59(2):327-35. PubMed ID: 2983911
    [Abstract] [Full Text] [Related]

  • 14. Expression of myeloid and major histocompatibility antigens on small cell carcinoma of the lung cell lines analyzed by cytofluorography: modulation by gamma-interferon.
    Ball ED, Sorenson GD, Pettengill OS.
    Cancer Res; 1986 May 15; 46(5):2335-9. PubMed ID: 3008987
    [Abstract] [Full Text] [Related]

  • 15. Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma.
    Ryschich E, Nötzel T, Hinz U, Autschbach F, Ferguson J, Simon I, Weitz J, Fröhlich B, Klar E, Büchler MW, Schmidt J.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):498-504. PubMed ID: 15701833
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of HLA class I molecules in primary oral squamous cell carcinomas and cell lines.
    Tang Q, Zhang J, Qi B, Shen C, Xie W.
    Arch Med Res; 2009 May 15; 40(4):256-63. PubMed ID: 19608014
    [Abstract] [Full Text] [Related]

  • 17. Expression of intercellular and vascular cell adhesion molecules and class II major histocompatibility antigens in human lungs: lack of influence by conditions of organ preservation.
    Hasegawa S, Ritter JH, Patterson A, Ockner DM, Sawa H, Mohanakumar T, Cooper JD, Wick MR.
    J Heart Lung Transplant; 1995 May 15; 14(5):897-905. PubMed ID: 8800726
    [Abstract] [Full Text] [Related]

  • 18. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.
    Grandis JR, Falkner DM, Melhem MF, Gooding WE, Drenning SD, Morel PA.
    Clin Cancer Res; 2000 Jul 15; 6(7):2794-802. PubMed ID: 10914726
    [Abstract] [Full Text] [Related]

  • 19. [Autoimmunity in patients with bronchogenic carcinomas: occurrence of antibodies against nuclear antigens, chromosomes and ds-deoxyribonucleic acid].
    Dellen H, Seemayer NH.
    Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Sep 15; 177(6):451-68. PubMed ID: 6322478
    [Abstract] [Full Text] [Related]

  • 20. HLA expression in basal cell carcinomas.
    Garcia-Plata D, Mozos E, Sierra MA, Peña J, Solana R.
    Invasion Metastasis; 1991 Sep 15; 11(3):166-73. PubMed ID: 1834604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.